FDA, HMOs to Analyze Medication Effects on 1 Million U.S. Births
Posted Jan 08 2010 8:27am
WebMD reports, "...the Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP)...is a collaboration between the FDA, Kaiser Permanente, Vanderbilt University (using Tennessee Medicaid data), and a consortium of HMOs called the HMO Research Network Center for Education and Research in Therapeutics (managed by Harvard University). The study will analyze health care data on about 1 million U.S. births from 2001 to 2007. The idea is to gather information on all medications prescribed for pregnant women and to look for health effects and birth outcomes."